Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

A 2983Session 222

Provides sales and use tax exemption for purchases of rapid or laboratory tests for purposes of detecting infections.

Introduced

ASSEMBLY, No. 2983

STATE OF NEW JERSEY

222nd LEGISLATURE

PRE-FILED FOR INTRODUCTION IN THE 2026 SESSION


Sponsored by:

Assemblyman ERIK PETERSON

District 23 (Hunterdon, Somerset and Warren)

SYNOPSIS

     Provides sales and use tax exemption for purchases of rapid or laboratory tests for purposes of detecting infections.

CURRENT VERSION OF TEXT

     Introduced Pending Technical Review by Legislative Counsel.


An Act providing a sales and use tax exemption for sales of certain viral tests or antibody tests for purposes of detecting infections, supplementing P.L.1966, c.30 (C.54:32B-1 et seq.).

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

     1.    Receipts from sales of rapid or laboratory viral tests or antibody tests, including, but not limited to, molecular and antigen tests, utilized for the purpose of detecting infections, such as SARS-CoV-2, are exempt from the tax imposed under the “Sales and Use Tax Act,” P.L.1966, c.30 (C.54:32B-1 et seq.).

     2.    This act shall take effect immediately and apply to sales occurring on or after the first day of the second month next following enactment.

STATEMENT

     This bill exempts from New Jersey sales and use tax purchases of rapid or laboratory viral tests or antibody tests.  The exemption will apply, but not be limited to, molecular and antigen tests utilized for detecting infections, such as SARS-CoV-2.

Official text from the New Jersey Legislature. Formatting has been adapted for reading on Ratifi.